相关实验视频

Updated: May 10, 2025

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

通过Tregs分化调制识别TNFSF4^low-MSCs,优异地治疗异常性肺纤维化

Yuanyuan Xie¹, Qing Yi², Congwang Xu³

¹Clinical Stem Cell Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210009, China.

Stem cell research & therapy

|April 20, 2025

概括

具有较低瘤坏死因子超级家族4 (TNFSF4) 成员表达率的中酶体 stromal 细胞通过增强调节性 T 细胞和减少肺纤维化,显示出异常性肺纤维化治疗潜力. 这一发现提供了一种新的向治疗方法.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
肺部医学肺部医学

背景情况:

异形性肺纤维化 (IPF) 是一种进展性肺病,其病原不明,治疗方法有限.
IPF表现为呼吸短促和低氧化,严重影响患者的预后.
了解IPF的发病因子对于开发有效的治疗策略至关重要.

研究的目的:

研究介质细胞 (MSCs) 在治疗IPF中的治疗潜力.
专注于MSCs通过低瘤坏死因子超家族成员4 (TNFSF4) 途径调节调节性T细胞 (Tregs) 的能力.
确定具有IPF治疗最佳免疫调节效应的特定MSC亚型.

主要方法:

使用公共数据集和患者样本分析了IPF患者的免疫特征.
评估MSC对Treg在周围血液和肺组织中的比例的影响.
利用全基因组测序和集群分析来识别TNFSF4-低MSC亚型.
研究了TNFSF4-TNFRSF4信号在Treg调节中的作用.

主要成果:

低TNFSF4的MSC在小鼠模型中显示了增强的Treg调节和抗纤维性作用.
用低TNFSF4的MSC治疗增加了Treg比例,减少了肺纤维化,并改善了生存率.
确定TNFSF4-TNFRSF4信号传递对Treg生成和功能至关重要.

结论:

TNFSF4在IPF的MSC介导的Treg调制中发挥着关键作用.
基于TNFSF4表达的MSC亚型的选择为IPF提供了一个新的治疗策略.
通过特定的MSC准免疫反应和纤维化,为IPF治疗提供了一个有希望的途径.

关键词:

纤维化疗法治疗纤维化异形性肺纤维化症异形性肺纤维化症免疫调节是一种免疫调节.介质细胞层细胞是介质细胞层细胞.监管性T细胞监管性T细胞在TNFSF4中.

更多相关视频

A Protocol for Using Förster Resonance Energy Transfer (FRET)-force Biosensors to Measure Mechanical Forces across the Nuclear LINC Complex

A Protocol for Using Förster Resonance Energy Transfer (FRET)-force Biosensors to Measure Mechanical Forces across the Nuclear LINC Complex

Published on: April 11, 2017

Nanopodia - Thin, Fragile Membrane Projections with Roles in Cell Movement and Intercellular Interactions

Nanopodia - Thin, Fragile Membrane Projections with Roles in Cell Movement and Intercellular Interactions

Published on: April 3, 2014

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...